We present the complete sequence of an mRNA which 1s Induced by estrogen 1n the human breast cancer cell line MCF-7 [pS2 mRNA, Masiakowski et al., Nucleic Adds Res. 10, 7895-7903 (1982)]. Primer extension and cloning of double-stranded cDNA (ds-cDNA) Into a vector designed to make full-length cDNA were used to determine the sequence of the fifteen 5'-terminal nucleotides which were not present 1n the original pS2 ds-cDNA clone. The mRNA sequence has a major open reading frame encoding 84 ami noadds, flanked by a 40 nucleotide 5'-untranslated region and a 198 nucleotide 3'-untranslated region preceding the polyA tall. The 3'-untranslated region contains a polyadenylation signal, AUUAAA, 14 nucleotides upstream from the polyA tall. The derived protein sequence contains a putative signal peptide region suggesting that the protein may be secreted. The nucleotide and derived ami no-add sequences were compared to previously determined sequences, particularly to those of hormone-regulated proteins and growth factors, and no obvious similarities were observed.
INTRODUCTION
Considerable work has been done 1n recent years to determine how steroid hormones modulate gene expression. The mouse mammary tumor virus (MMTV) provides an excellent model system to study the molecular mechanisms underlying Induction of transcription of a specific gene by glucocorticoids (for refs see [1] [2] [3] [4] . The human pS2 gene whose double-stranded cDNA (ds-cDNA) has been cloned recently by our group (5) may constitute a counterpart of the MMTV system for studying the transcriptional regulation of gene expressIon 1n mammals by estrogen. Indeed, we have shown that the Induction of expression of the pS2 gene by estrogen 1n the human breast cancer cell line MCF-7 1s a primary transcMptional event (6) . In addition, pS2 RNA has been found only 1n MCF-7 cells and 1n biopsies of some breast cancers (7, 8) .
It cannot be detected 1n normal breast tissue. Thus the pS2 gene may be useful for clinical studies as well as basic studies aimed at elucidating how estrogens work at the molecular level. The MCF-7 cell line and pS2 gene provide a more convenient system for 1n vitro genetics studies on estrogen-Induced genes than the popular chick oviduct, which has been extensively used to study the molecular mode of action of steroid hormones (for discussion of this point, see ref. 7) .
We report here the complete nucleotide sequence of the pS2 mRNA and show that 1t contains an open reading frame coding for a small protein which might be secreted and presents no obvious similarities to already known proteins.
MATERIALS AND METHODS
Cell culture MCF7 cells were a gift from the Michigan Cancer Foundation and were maintained 1n Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (G1bco) and 0.6 ^g/ml Insulin (Sigma). Preparation of RNA Total RNA was prepared by homogenization of cells 1n urea-SDS and precipitation with L1C1 according to the procedure of Auffray and Rougeon (9) except that following overnight precipitation with L1C1, the RNA was extracted twice with phenol-chloroform-1so-amyl alcohol (50/50/1). Cloning of full-length pS2 double-stranded cDNA.
The construction of recombinant plasmids for cloning full-length dscDNA (10) was as described by Breathnach and Harris (11) . As outlined 1n Fig. 4 , a T-ta1led primer fragment 1s used to prime cDNA synthesis from polyadenylated RNA. The cDNA-roRNA hybrid 1s then tailed with dC residues and Is annealed to a linker fragment derived from the plasmid pSVE (11) carrying a tall of dG residues. Following Ugation, the RNA 1s then replaced by DNA using RNase H and DNA polymerase I. The advantage of this cloning technique 1s that SI nuclease is not used, leading to a greater retention of sequences representing the 5'-ends of mRNAs.
This technique was used to construct a ds-cDNA library from polyadenylated RNA of estrogen-treated MCF-7 cells. The ds-cDNA library was screened by hybridization with the nick-translated PstI fragment A (Fig.  1A) of the pS2 ds-cDNA previously cloned by Mas1akowsk1 et al. (5) . Two clones were detected. Their cDNA Inserts were approximately the same length as that of the original pS2 ds-cDNA. These recorabinant plasmids, designated pSVESl and pSVES2 (F1g. 4), were sequenced from the unique Ball site of the ds-cDNA. In practice, the Ball sites of pSVESl and pSVES2 were converted Into Sail sites by cleavage with Ball and Sail, followed by repair with DNA polynerase I and Ugation (Ball cleaved DNA very Inefficiently in our 
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RESULTS
Sequencing of the original pS2 double-stranded cDNA.
The previously cloned pS2 ds-cDNA, corresponding to a polyadenylated RNA whose level 1n MCF-7 cells 1s rapidly Increased by addition of estradiol to the culture medium (5), was sequenced directly using the procedure of Maxam and Gilbert (12) . The restriction map shown 1n Fig. 1A Indicates the presence of restriction endonuclease sites as determined by a combination of direct multiple restriction endonuclease analysis and sequence analysis. This pS2 ds-cDNA contains two Internal PstI sites yielding three fragments, A, B and C, of approximately 320, 100 and 150 nucleotides in length (dC-tailed ds-cDNA was annealed to pBR322 dG-taHed at Its PstI site; so the dscDNA 1s flanked by PstI sites). These PstI sites, together with a PvuII and a Sad site, were the most useful sites for 5' end-labeling the fragments and subsequent sequence determination. Some TaqI sites were also used as labeling sites to confirm sequence determinations and for overlapping the sequences of adjacent fragments. The sequence of pS2 ds-cDNA was determined for the most part on both DNA strands to ensure accuracy as outlined In F1g. 1A. The extreme 5' part of the sequence was determined, after subcloning PstI fragment A Into the PstI site of M13mp7 (15), by sequencing from the EcoRI and BamHI sites of the repHcative form of the M13 ds-cDNA recombinant. The 5'-end of the pS2 ds-cDNA was also sequenced from an upstream Hpall site of pBR322 (Fig-1A ) using a Hpall-Rsal fragment. The 3'-end region of the original pS2 ds-cDNA was also confirmed by sequencing from the 5' end-labeled EcoRI site of a M13mp7-pS2 ds-cDNA recombinant containing the PstI fragment C of the original pS2 ds-cDNA.
All of the restriction sites determined from mapping data were accounted for by sequence analysis. Some of the restriction sites predicted by the sequence were not cut by the appropriate enzyme. These Include the Avail site at position 76 and the Clal site at position 482 (see F1g. 5). This 1s due to a C and an A methylation within the Avail and Clal sites, respectively (16) . The Clal site was cleaved (A. Brown, personal communication) when the pS2 ds-cDNA clone was transfected Into a dam" strain of E.coH where adenine methylation does not occur.
The sequence data {Fig. 5) Indicates that the original pS2 ds-cDNA clone contains a 559 nucleotide Insert Including 20 and 14 dCMP residue tails at the 5' and 3'-ends, respectively, and a 3'-end 50 nucleot1de-long polydA tall. Two approaches were used to determine the 5'-terminal sequence of pS2 mRNA. Determination of pS2 mRNA 5'-end sequence by primer extension Previous estimates of the size of the mRNA corresponding to pS2 dscDNA by electrophoresis on denaturing methyl mercury hydroxide-agarose or formaldehyde-agarose gels were approximately 600 nucleotides, using an Alul digest of pBR322 as size marker (5) . Since this length was not very different from that of the ds-cDNA Insert present 1n the original pS2 ds-cDNA clone, 1t appeared feasible to determine the number of any additional nucleotides at the 5'-end of the pS2 mRNA using primer extension. Two primers, the 23 nucleotide BalI-Sau3AI fragment and the 48 nucleotide TaqI-TaqI fragment were prepared as described 1n Materials and Methods (see F1gs. IB and When the 48 nucleotide long Taql-TaqI fragment (dashed arrows, Fig.  2A ) was used as a primer for extension with reverse transcriptase, a band of approximately 260 nucleotides was observed upon gel electrophoresis after digestion of the elongated product with SI nuclease (lane 2, arrowhead) together with some prematurely terminated cDNA. Taking Into consideration that this transcript Included the 48 nucleotide primer and 197 nucleotides previously sequenced at the 5'-end of the original pS2 ds-cDNA (see Fig. 5 ), this result Indicated that the original clone was missing approximately 15 bp of the 5'-end of the mRNA. We then used as primer the 23 nucleotide BallSau3AI fragment (dashed arrow, Fig. 2B ) that 1s closer to the 5'-end to determine the sequence of the extended transcript (as seen 1n F1g. 2B lane 1, the primer fragment preparation contained some additional non-Identified labeled DNA fragments). A single band was observed after elongation with reverse transcriptase, followed by NaOH or SI nuclease digestion (F1g. 2B, lanes 2 and 3, arrowhead). This band was estimated to be approximately 65 nucleotides long on the basis of relative mobility using a Mspl digest of pBR322 as size marker. Therefore, the primer was elongated by about 42 nucleotides. Taking Into consideration that these 42 nucleotides Include 29 nucleotides previously sequenced at the 5'-end of the original pS2 ds-cDNA (see F1g. 5), this result Indicated that approximately 13 nucleotides were missing at the 5'-end of the original ps2 ds-cDNA. The "65 nucleotide" band was eluted from a preparative gel and sequenced (F1gs. 1C, 3A and results not shown). The fidelity of the primer extension technique was demonstrated by the Identity of the sequence obtained using this method with that determined 1n the original pS2 ds-cDNA for the 29 nucleotide segment located upstream from the Ball site. However, using this technique, 1t was not possible to determine conclusively the nature of the last two nucleotides at the 5'-end of the mRNA. tic promoters and processing signals (11) . One of these expression vectors was used to construct a ds-cDNA library from polyadenylated RNA of MCF-7 cells grown 1n the presence of estradiol (F1g. 4 and Materials and Methods). Two clones (pSVESl and pSVES2) were detected by hybridization with the nick-translated original pS2 ds-cDNA. Their ds-cDNA Insertions were approximately the same length as the original pS2 ds-cDNA and contained the same major restriction enzyme sites. The 5'-end region of the pS2 ds-cDNA Inserts present 1n pSVESl and pSVES2 were sequenced from the Ball site as described 1n Materials and Methods.
The result of the sequence determination for pSVESl 1s shown 1n F1gs. 2C, ID and 3B. Five nucleotides preceeding the dC homopolymer tall which could not be determined from the primer extension sequencing gel, were characterized. However, although both pSVESl and pSVE2 clones gave the same 5'term1nal sequence, the G nucleotide shown by the arrow 1n F1gs. 2C and 3B was present only 1n pSVESl. That this extra G corresponds 1n fact to a contamination of the dCTP used for dC tailing during the construction of the ds-cDNA library was confirmed by sequencing the 5'-end region of a cloned pS2 "genomic" gene, which Indicated the absence of a BamHI site (F1g. ID) at the 5'-end of this gene (17) . From all of these results, 1t 1s clear that the original pS2 ds-cDKA was missing 15 base pairs at Its 5'-end and that the first base of pS2 RNA 1s an A. Two regions of complementarity with the 3'-end sequence of 18S rRNA of higher eukaryotes occur 1n the 5'-untranslated region of pS2 RNA. The first sequence, 5'-CCUU-3', which occurs 19 nucleotides downstream from the RNA 5'-terminus, is complementary to nucleotides 3'-GGAA-5' of the conserved sequence 3' -AUUACUAGGAAGGCGUCC-S' , present at the 3'-end region of the 18S rRNAs of higher eukaryotes (19) . In addition, the sequence, 5'-GCAG-3', which 1s located five nucleotides downstream from the CCUU sequence, 1s complementary to nucleotides 3'-CGUC-5' at the 3'-end of the 18S rRNA. This 1s consistent with the observation that there is some base sequence complementarity between the 5'-untranslated region of a large number of eukaryotic mRNAs and the 3'-end region of 18S rRNAs, which might play a role 1n Initiation of translation (for refs., see [19] [20] [21] .
The 3'-untranslated region consists of 195 nucleotides between the translation stop signal and before the polyA tall. It has been shown that the hexanucleotide A-A-U-A-A-A found 15-25 nucleotides upstream from the polyadenylation site 1n most eukaryotic mRNAs serves as part of the signal for polyadenylation (22) (23) (24) . In pS2 mRNA, the sequence AUUAAA 1s present 14 nucleotides upstream from the polyA tract. This somewhat atypical sequence has also been reported for other eukaryotic genes (for refs., see 25, 26) . Sequence of the putative pS2 protein.
An ami no add sequence derived from the sequence of the pS2 mRNA 1s shown 1n F1g. 5. It corresponds to a possible 84 amino adds long polypept1de with a molecular weight of 9140 daltons. The amino add sequence shown here represents the longest open reading frame. The translational initiation site was tentatively assigned to the methionine codon at position 41 of the mRNA sequence, rather than to the two AUG located further downstream (positions 50 and 89) for the following reasons. According to the translational "scanning model" (27) , eukaryotic Mbosoraes bind to the 5'-terminus of mRNA and migrate along the mRNA sequence until they encounter the first AUG triplet, which, by virtue of Its position, 1s the initiation codon. An extended version of the scanning model (28, 29) was proposed 1n which the nucleotides flanking the AUG Initiation codon play an Important role 1n the recognition by eukaryotic ribosomes, the most favorable sequence for favorable sequence An examination of the N-term1nal sequence of the presumptive pS2 protein suggests that 1t contains a signal peptide typical of proteins which are secreted (30) . A number of signal peptides have been analyzed in prokaryotes and eukaryotes 1n terras of both ami no add sequences and functions (31) (32) (33) (34) (35) . These peptides consist of 15-30 amino add residues with a highly hydrophobic central core. According to the loop model of secreted proteins suggested by Inouye and Halegoua (31), and modified recently by Von Heijne (34) and Perlman and Halvorson (35) , the signal peptide 1s composed of three sections. Section I 1s the N-terminal section having one or more basic amino add residues. Section II, the central portion, the core, 1s composed on the average of 12 hydrophobic amino add residues. The end of the core section is defined by a charged residue, a sequence of amino add residues which may Introduce a p-turn 1n a polypeptide or an Interruption In potential a-hel1x or p-extended strand structure. In section III, following the hydrophobic core and preceding the cleavage site, there 1s a highly non-random and localized distribution of alanine within the Initial 8 positions. The most frequent sequence preceding the signal peptidase cleavage site has been observed to be Ala-X-Ala and the cleavage site 1s preferentially located after the sixth am1no-acid following the core sequence. As Indicated 1n F1g. 5, the sequence starting with the first methionine exhibits features that are characteristic of a signal peptide. There is a basic lysine residue 6 ami no adds away from this methionine (Section I). The sequence then contains 12 non-polar hydrophobic am1no-ac1ds interrupted by only 2 polar am1no-acid residues (cysteine and serine; Section II). According to the model, the signal peptidase cleavage site 1s likely to occur following alanine at position 26 (Section III). This would allow a signal peptide sequence consisting of 26 am1no-acid residues and a secreted protein of 58 residues. Alternatively, the signal peptidase cleavage site could be located after the glycine at position 21. Such a location, which would also be 1n agreement with the model, would reduce the size of the core section (II) to 8 residues, Instead of 13, and Increase the length of the secreted protein to 63 residues (see F1g. 5). Thus the molecular weight of the secreted protein would be either 6450 daltons or 6970 daltons depending on where the signal peptidase cleavage occurs.
Besides the putative hydrophobic signal peptide sequence present a the ami no terminus of pS2 protein, there is another stretch of 8 very hydro phobic residues near the carboxyl terminus (positions 64-71) and a moderately hydrophobic stretch of 9 residues 1n the central portion of the coding sequence (positions [41] [42] [43] [44] [45] [46] [47] [48] [49] . The overall percentage of hydrophobic arainoadds in the sequence 1s 30%. The carboxyl terminus 1s very hydrophiHc, consisting of a stretch of 10 hydrophiHc residues, 4 of which are glutamic acid and 1 aspartic add. These am1no-acid arrangements are reminiscent of transmerabrane proteins, such as Is observed for the heavy chains of the major h1stocompat1b1Hty complex antigens (36, 37) glycophoMn (38) and membrane IgM (39) . An examination of the charged residues 1n the putative unprocessed protein Indicates that there are 11 addle residues (8 glutamic add and 3 aspartic add residues), while there are 5 basic residues (2 lysine and 3 arginine residues). The putative 58 am1no-add processed polypeptide would contain 9 acidic and 4 basic residues. Codon usage. Table I shows the codon usage for pS2 mRNA The codon usage is nonrandom and very similar to that found 1n other eukaryotic mRNAs (see for Instance : [40] [41] [42] [43] [44] . It reflects a high preference for G or C In the third The pS2 mRNA sequence 1s characterized by a high overall G + C content (56% compared to the average 40% G + C content of the human genome).
The G + C content decreases drastically as one enters the last 60 nucleo-tides of the 3' untranslated region : 62.5% G + C 1n the 5'-untranslated region, 58% 1n the coding region, 62% and 31% 1n the first 37 nucleotides and in the last 60 nucleotides of the 3'-untranslated region, respectively. In the coding region, this bias 1s due to an assymetry 1n the base choices for the third codon position : 68% for G + C and 32% for A + T. A similar bias has been observed for other mammalian mRNAs (for refs., see 45). In addition, there 1s no bias against the CpG dinucleotide. The ds-cDNA sequence has a high frequency of restriction sites for the "CpG" restriction enzymes such as Hhal, Hpall, FnuDII and Taql. The CpG/GpC ratio 1s 0.77 1n the protein coding region. This ratio 1s similar to that observed for rat skeletal a-act1n (0.78), human a-glob1n (0.80) and human proopiomelanocortin (0.79), and very different from that observed for human cardiac a-act1n (0.51), human growth hormone (0.45) and human p-glob1n (0.14) (for refs., see 45) . The high CpG content of the sequence of pS2 mRNA 1s also reflected 1n the presence of two rare ACG threonine codons (44) at positions 30 and 47. It has been observed by Hanauer et al. (45) that 1n human mRNA sequences, a large excess of G + C at the third codon position 1s correlated with an absence of bias against CpG dinucleotides. These authors have suggested that the particular codon usage found 1n some mRNAs reflects more the presence of a gene in a specific genomic region which differ 1n Its base composition over long distances, than some selective pressure related to protein synthesis mechanims.
The Initiation codon was tentatively assigned to the methionine triplet at positions 41-43, which 1s the first AUG codon within the deduced mRNA sequence. The sequence of the 21-26 amino add residues starting with this Initial methionine exhibits features that are characteristic of the signal peptides present at the amino terminus of secretory proteins (see Results). Possible sites for cleavage of the signal peptide are located after the glydne residue at position 21 or after alanine residue at position 26. Thus after removal of the signal peptide, the putative 9120 dalton preprotein might be processed to a polypeptide of 58 or 63 am1no-ac1d residues, and the molecular weight reduced to 6450 daitons or 6970 daltons. After removal of the signal peptide, the remaining protein would contain 7 cysteine residues which are distributed throughout the sequence. These residues may form d1sulphide bonds, as 1s the case for peptide hormones such as Insulin and growth hormone (46) . There is also a hydrophobic stretch of 8 am1no-acid residues near the carboxyl terminus of the sequence extending from the glydne residue at position 64 to the proline residue at position 71. The presence of this second hydrophobic region suggests that 1n addition to being secreted, the protein could conceivably be a transmembrane protein.
Experiments are currently 1n progress to Investigate 1n vivo and 1n vitro the protein product corresponding to pS2 mRNA.
The molecular weight of the putative pS2 protein does not correspond to the size of any of the various polypeptides which, up to now, have been shown to be Induced by estrogen in MCF-7 cells (see 47 and 48) . The pS2 protein does not correspond either to the product of the transforming gene which has been characterized in the genome of MCF-7 cells (49), since this gene 1s not cut by BamHI and EcoRI restriction enzymes, whereas the pS2 gene 1s cut by these two enzymes within its first Intron (17) . The sequence of the pS2 ds-cDNA and the derived polypeptide were compared with the nucleic add and protein sequence databases at the National Biomedical Research Foundation, Georgetown University Medical Center, Washington, D.C. by Dr. M.O. Dayhoff. No closely related DNA or amino-add sequence homologles were found. However, some characteristics of the am1no-acid sequence of pS2 protein (low molecular weight, high cysteine content, putative signal peptide sequence) prompted us to compare its structure to that of known growth factors. Some overall structural similarities were observed with the aminoadd sequences of the growth hormone-dependent 1nsul1n-l1ke polypeptides termed somatomedins, and particularly with human 1nsul1n-l1ke growth factor I and II (IGF I and II). The length of the am1no-add sequence of pS2 protein is similar to that of the human 1nsulin-l1ke growth factors; 58 or 63 am1no-ac1ds for the pS2 protein after cleavage of the putative signal peptide sequence compared to 67 and 70 amino-adds, respectively for human IGF I and II (50, 51) . The putative pS2 protein and IGFs are also similar in their richness 1n cysteine residues. The IGFs contain 6 half-cystine residues which can form 3 disulphide bonds. The am1no-ac1d sequence of pS2 protein contains 8 half-cystine residues, 7 of which are located after the putative signal peptide sequence, and thus also has the capacity to form 3 disulphide bonds. In addition, the arrangement of some cystine residues appears to be similar 1n the sequence of the pS2 proteins and IGFs. In both cases the sequence Cys-Cys-Phe (positions 56-58 1n pS2 protein) 1s present and followed by two additional cysteine residues located further downstream. Cysteine residue clusters have also been found in other growth factors, such as nerve growth factor (52, 53) , epidermal and tumor growth factor (see 54) and plalelet-derived growth factor (55), but there Is no obvious aminoadd sequence homologies between the putative pS2 protein and these growth factors. However, this absence of homology does not rule out that the pS2 protein might be an estrogen-inducible growth factor, since there is no sequence similarity between some of these growth factors either. Whether or not the pS2 protein is a member of the estromedin family (56), a group of estrogen-indudble growth factors which are still poorly characterized, 1s an Interesting question with Implications for both the mode of action of estrogens and the etiology of human breast cancer.
